Ortin Global share price

ABOUT Ortin Global

• Industry Biotechnology & Drugs
• ISIN INE749B01020
• BSE Code 539287
• NSE Code ORTINGLOBE

Ortin Global Limited, formerly Ortin Laboratories Limited, is engaged in manufacturing and trading of pharmaceuticals, drugs, and intermediates. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. Its products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, and others. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. It is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.

Ortin Global Management

• Sanka Krishna Murthy Chief Executive Officer, Acting Compliance Officer, Managing Director
• Sanka Kumar Chief Financial Officer, Whole-Time Director
• Sanka Venkateswarlu Director - Marketing, Whole Time Director
• Datla Raju Whole Time Director